Viral modulation of the CXCL12/CXCR4/CXCR7 axis: mechanisms, impacts on immunity and oncogenesis, and therapeutic opportunities
Cancer Treatment and Research Communications · 2026
DOI: 10.1016/j.ctarc.2026.101247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Usamah Sayed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: u…. Hauptthemen laut MEDLINE: Chemokine CXCL12, Receptors, CXCR, Receptors, CXCR4, Neoplasms. Die Arbeit nennt 295 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The CXCL12/CXCR4/CXCR7 chemokine axis is a spatial signaling network that links cell positioning to immune function, tissue repair, vascular stability, and niche retention. Under physiological conditions, CXCL12 gradients, receptor bias, receptor crosstalk, and ligand scavenging coordinate leukocyte trafficking, stem/progenitor-cell localization, endothelial integrity, and tissue remodeling. Viruses frequently exploit this system to facilitate entry, dissemination, immune evasion, persistence, and, in some contexts, virus-associated oncogenesis. Across herpesviruses, retro/lentiviruses, hepatotropic viruses, respiratory viruses, HPV, and neurotropic viruses, several recurring strategies emerge: receptor-interface remodeling through heterodimerization, allosteric modulation, or viral GPCR activity; post-translational modification of receptors, including tyrosine sulfation; transcriptional, epigenetic, and miRNA-mediated regulation that sustains CXCL12 production or shifts CXCR4/CXCR7 expression; and redistribution or sequestration of CXCL12 within tissue microenvironments. These mechanisms reshape antiviral immunity by altering leukocyte recruitment, promoting localized inflammation, restricting effector-cell access, and supporting immune-suppressive niches. In virus-associated cancers, CXCL12-axis rewiring contributes to EMT, invasion, angiogenesis, stromal co-option, immune exclusion, and therapy resistance. In this review, we discuss how diverse viruses reprogram the CXCL12-CXCR4-CXCR7/ACKR3 axis at molecular and spatial levels and connect these changes to immune mislocalization, viral persistence, and oncogenic progression. We also evaluate therapeutic opportunities, including CXCR4/CXCR7 antagonists, CXCL12-neutralizing strategies, and biomarker-guided combinations with targeted therapies or immunotherapies. We propose that this axis should be approached not as a uniformly pathogenic pathway, but as a context-dependent spatial system whose therapeutic modulation must be tailored to viral species, tissue compartment, disease stage, and receptor state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: u.sayed@ammanu.edu.jo.
- College of Pharmacy, Alnoor University, Nineveh, Iraq. Electronic address: aya.mohammed@alnoor.edu.iq.
- Department of Traumatology, Orthopedics, Neurosurgery and Ophthalmology, Samarkand State Medical University, Samarkand, Uzbekistan.
- Department of Medicine, Termez University of Economics and Service, Termez, Uzbekistan.
- Al-Zahrawi University College, Karbala, Iraq. Electronic address: rasim_salih@yahoo.com.
- Pharmacy college, Al-Farahidi University, Baghdad, Iraq. Electronic address: mohanedadilphd@gmail.com.
Zitieren
APA
Sayed, U., Dhiaa, A. M., Mansurov, D., Kholboyev, N., Salih, R. M., Adil, M., & Alkayyat, S. (2026). Viral modulation of the CXCL12/CXCR4/CXCR7 axis: mechanisms, impacts on immunity and oncogenesis, and therapeutic opportunities. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101247
Vancouver
Sayed U, Dhiaa AM, Mansurov D, Kholboyev N, Salih RM, Adil M, et al. Viral modulation of the CXCL12/CXCR4/CXCR7 axis: mechanisms, impacts on immunity and oncogenesis, and therapeutic opportunities. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101247
BibTeX
@article{Sayed2026,
author = {Sayed, Usamah and Dhiaa, Aya Mohammed and Mansurov, Djaloliddin and Kholboyev, Norbek and Salih, Rasim M and Adil, Mohaned and Alkayyat, Safa},
title = {Viral modulation of the CXCL12/CXCR4/CXCR7 axis: mechanisms, impacts on immunity and oncogenesis, and therapeutic opportunities},
journal = {Cancer Treatment and Research Communications},
year = {2026},
doi = {10.1016/j.ctarc.2026.101247}
}
EUVIMED